El Salvador’s $1.6B Bitcoin City Investment Unveiledby John Darbie 14.08.2024El Salvador partners with Yilport Holdings to build Bitcoin City, boosting trade and modernizing ports with a $1.6B investment.
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapyby Lilu Anderson 14.08.2024Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
BP Tech May Drill on Mars After NASA Dealby Lilu Anderson 14.08.2024BP's tech could explore Mars or Moon post NASA deal, sharing expertise from hostile environments.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
MITRE Enhances ICS ATT&CK Evaluationsby Lilu Anderson 13.08.2024MITRE seeks contributions to enrich ICS ATT&CK emulation by evaluating insider threat behaviors in industrial control systems.
AI Predicted to Boost Returns in Biotech Stocksby Lilu Anderson 13.08.2024AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
InspireMD Eyes US Launch Amid Revenue Growthby Mark Eisenberg 11.08.2024InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
Effective ICS Patch Management for Securityby Lilu Anderson 11.08.2024Adopt strategic patch management in ICS for security and stability amid rising cyber threats. Ensure minimal operational disruptions.
Stock Market Turbulence Explained: Yen Trade & Moreby Mark Eisenberg 10.08.2024Discover factors causing recent stock market volatility and expert advice for navigating economic uncertainties.
Organogenesis Q2 Revenue Surpasses Forecasts at $130Mby Mark Eisenberg 10.08.2024Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.